Evidence map›Paper›PMID 41918845›Full record

ArticleInternational journal of nanomedicine2026

Motunrayo V Badejo, Kudakwashe Nyambo, Ephifania Geza, Dominic de Oliveira, Hleziphi V Mpundu, Liezel Catharine Smith, Michael Claeys, Siyabonga Ngubane, Craig Kinnear, Deané Basson and 6 more

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Motunrayo V Badejo *South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Kudakwashe Nyambo *South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Ephifania GezaDepartment of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-7873-2728
Dominic de OliveiraDepartment of Chemical Engineering, University of Cape Town, Cape Town, South Africa.
Hleziphi V MpunduSouth African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Liezel Catharine SmithSouth African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Michael ClaeysDepartment of Chemical Engineering, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-5797-5023
Siyabonga NgubaneDepartment of Chemistry, University of Cape Town, Cape Town, South Africa.ORCID 0000-0003-2091-0936
Craig KinnearSouth African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Deané BassonCenter for High Resolution Transmission Electron Microscope, Physics Department, Nelson Mandela University, Gqeberha, South Africa.
Genevéve MarxCenter for High Resolution Transmission Electron Microscope, Physics Department, Nelson Mandela University, Gqeberha, South Africa.
Ezra Jacobus OlivierCenter for High Resolution Transmission Electron Microscope, Physics Department, Nelson Mandela University, Gqeberha, South Africa.
Lucinda BaatjiesSouth African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Andre G LoxtonSouth African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0003-0659-9803
Kudzanai I TapfumaSouth African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-5161-6695
Vuyo MavumengwanaSouth African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0003-4672-6176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Tuberculosis, caused by Methods: SPIONs were synthesized through chemical co-precipitation and functionalized with metals to create bimetallic (Ag@SPIONs, Au@SPIONs, Cu@SPIONs, Ni@SPIONs) and trimetallic (Ag-Cu@SPIONs, Ag-Ni@SPIONs) nanoparticles. The physicochemical characteristics of the metal-coated SPIONs were assessed using microscopy and spectroscopy techniques. Antimicrobial activity of the nanoparticles against Results: Transmission electron microscope analysis revealed average particle sizes of 10.28 nm for SPIONs, and 12.51 nm, 17.07 nm, 14.60 nm, 16.18 nm, 14.68 nm, and 15.00 nm for Ag@SPIONs, Au@SPIONs, Cu@SPIONs, Ni@SPIONs, Ag-Cu@SPIONs, and Ag-Ni@SPIONs, respectively, all displaying a predominantly spherical morphology. Antimicrobial testing demonstrated a potency ranking: Ag-Cu@SPIONs (1.95 µg/mL) > Ag-Ni@SPIONs (3.9 µg/mL) > Ag@SPIONs (3.9 µg/mL) > Cu@SPIONs (62.5 µg/mL) > Ni@SPIONs (>62.5 µg/mL). Gene expression analysis revealed that Ag@SPIONs and Ag-Cu@SPIONs induced strong upregulation of heavy-metal detoxification genes, whereas Cu@SPIONs significantly enriched pathways linked to valine, leucine, and isoleucine degradation, and fatty acid and propanoate metabolism. Discussion: This study demonstrates that metal-coated SPIONs possess strong antimycobacterial activity and significantly modulate key metabolic and stress-response pathways in Conclusion: Overall, the findings demonstrate that metal-coated SPIONs hold significant promise as alternative antimycobacterial agents. However, comprehensive in vivo studies are required to fully determine their therapeutic effectiveness and safety.

Indexed as

Anti-Bacterial AgentsMagnetic Iron Oxide NanoparticlesMycobacterium smegmatisParticle SizeSilverAnti-Bacterial AgentsSilverantimicrobial activitygene expressionsnanomedicinesuperparamagnetic iron oxide nanoparticlestuberculosis

Identifiers

PMID41918845
PMCPMC13033937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.